期刊文献+

BNP、CRP和cTNI测定对AECOPD患者危险分层及预后判断的临床价值 被引量:15

The research of clinical value research of BNP,CRP and cTNI in risk stratification and prognostic evaluation about BNP,CRP and cTNI determination in AECOPD patients
原文传递
导出
摘要 目的:探讨血浆脑钠肽(BNP)、C反应蛋白(CRP)、肌钙蛋白I(cTNI)水平与慢性阻塞性肺疾病急性加重期(AECOPD)患者危险分层及预后的关系。方法:选择AECOPD患者236例及健康对照组30例,按照2007ATS共识对患者进行评估分级,分为轻度、中度和重度三级,分别测定其血浆BNP、CRP和cTNI浓度。同时统计住院病死率、6个月内病死率、6个月内再入院率,进行统计学分析。结果:①AECOPD组BNP(391.73±25.8)ng/L、CRP(19.74±1.63)mg/L、cTNI(0.19±0.046)μg/L显著高于对照组BNP(69.38±8.5)ng/L、CRP(7.15±0.86)mg/L、cTNI(0.10±0.031)μg/L,均P<0.05。②随着AECOPD患者病情加重(分级上升),血浆BNP、CRP和cTNI水平升高,住院病死率、6个月病死率和6个月内再入院率升高,3组之间的差异有统计学意义(P<0.05)。结论:血浆BNP、CRP和cTNI测定有助于AECOPD的危险分层和预后评估。 Objective: To investigate the relation between plasma brain natriuretic peptide (BNP), C-reactive protein (CRP) ,Cardiac troponin I (cTNI) and risk stratification or prognosis in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Method:We choosed 236 patients with AECOPD 236 cases and 30 healthy controls 30 cases were recruited. ,and estimated these These patients according to the 2007 ATS con- sensus, thenwere divided them into 3 grades according to the 2007 ATS consensus:mild, moderate and severe level. The plasma BNP,CRP and cTNI concentration were determined detected in all these patients and healthy controls cases. At the same time, The statistical analysis of inpatient mortality,mortality and rehospitalization rates within 6 months after discharge from hospital were down analized. Result:In AECOPD group,the Plasma concentration of BNP (391.73±25.8 ng/L) ,CRP (19.74±1.63 mg/L) ,cTNI (0. 19±0. 046 ILg/L) is significantly higher than that in control group (BNP P=0. 001,CRP P=0. 026,cTNI P=0. 008). In AECOPD group, the levels of BNP, CRP and cTNI showed a positivity relationshipwere positively related with patient classification and , inpatient mortality,mortality and rehospitalization rates with 6 months after discharge from hospital. Conclusion:Determina- tion Detection of plasma concentration of BNP,CRP and cTNI could help us to do evaluate risk stratification and prognosis evaluation of patients with AECOPD.
出处 《临床急诊杂志》 CAS 2014年第2期79-81,共3页 Journal of Clinical Emergency
关键词 慢性阻塞性肺疾病急性加重期 脑钠肽 C反应蛋白 肌钙蛋白I acute exacerbation of chronic obstructive pulmonary disease brain natriuretic peptide C-reactiveprotein cardiac troponin I
  • 相关文献

参考文献11

  • 1ALBERTSON T E,LOUIE S,CHAN A L. The diag- nosis and treatment of elderly patients with acute ex- acerbation of chronic obstructive pulmonary disease and chronic bronchitis[J]. J Am Geriatr Soc, 2010,58 : 570-579.
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8243
  • 3POOR H D,GIRGIS R,STUDER S M. World Health Organization Group Ⅲ pulmonary hypertension[J]. Prog Cardiovasc Dis,2012.55:119-127.
  • 4ORNEK T,TOR M, ALTIN R,et al. Clinical factors affecting the direct cost of patients hospitalized with a- cute exacerbation of chronic obstructive pulmonary disease[J]. Int J Med Sei. 2012,9: 285 - 290.
  • 5STOLZ D, BREIDTHARDT T, CHRIST-CRAIN M, et al. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD [J]. Chest, 2008,133 : 1088 - 1094.
  • 6陈令东,顾鹏.急诊室脑钠肽测定在呼吸困难鉴别诊断中的应用[J].实用医学杂志,2012,28(21):3568-3570. 被引量:18
  • 7李勇,杨永青.AECOPD患者血浆BNP、cTnI、UA测定对疾病诊断和治疗的临床观察[J].放射免疫学杂志,2011,24(2):167-169. 被引量:11
  • 8ROWE B H, BHUTANI M, STICKLAND M K, et al. Assessment and management of chronic obstructive pulmonary disease in the emergency department and beyond[J]. Expert Rev Respir Med, 2011, 5: 549- 559.
  • 9YE M, YU H, YU W, et al. Evaluation of the signifi- cance of circulating insulin like growth factor-1 and C- reactive protein in patients with chronic obstructive pulmonary disease[J]. J Int Med Res, 2012,40 : 1025 - 1035.
  • 10MARTINS C S,RODRIGUES M J,MIRANDA V P, et al. Prognostic value of cardiac troponin Ⅰ in patients with COPD acute exacerbation[J]. Neth J Med, 2009, 67:341-349.

二级参考文献29

  • 1叶永青.慢性阻塞性肺病患者血浆B-型钠尿肽水平及临床意义[J].实用临床医药杂志,2005,9(8):14-16. 被引量:18
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:280
  • 3Stolg D,Rasch H,Linka A,et al.A randomized controlled trial of bsentan in severe COPD[J].Eur Respir J,2008,32:619-628.
  • 4Leuchte HH,Baumgartner RA,Hounou ME,et al.Brain natriuretic peptide is a prognostic parameter in chronic lung disease[J].Am J Respir Crit Care Med,2006,173:744-750.
  • 5朱元钰,陈文斌.呼吸病学[M].第1版.北京:人民卫生出版社,2007,877-892.
  • 6Kardos P,Wencher M,Glaab T,et al.Impact of salmeterol fluticasone propionate versus salmeterol on exacerbations in severe chronic obstruction pulmonary disease[J].Am J Respire Crit Care Med,2007,175:144-149.
  • 7Hopkins WE,Chen Z,Fukagawa NK,et al.Increased atrial and brain natriuretic peptide in adults with congenital heart disease,enhanced understanding of the relationship hypoxia and natriuretic peptide secretion[J].Circulation,2004,109:2872-2876.
  • 8Tashkin DP,Cell B,Senn S,et al.A4-year trial of tiotropinum in chronic obstructive pulmonary disease[J].N Engl J Med,2008,359:1543-1554.
  • 9Sin DD,Man SF.Is systemic inflammation responsible for pulmonary hypertension in COPD?[J] Chest,2006,130:310-312.
  • 10Barnes PJ.Mediators of chronic obstructive pulmonary disease[J].Pharmacol Rev,2004,56:515-548.

共引文献8266

同被引文献117

引证文献15

二级引证文献114

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部